Abstract

Obesity and irritable bowel syndrome: a comprehensive review

Pickett-Blakely O1. Gastroenterol Hepatol (N Y). 2014 Jul;10(7):411-6.
 
     
Author information

1Dr Pickett-Blakely is the director of the Small Bowel Disorders and Nutrition Program in the Division of Gastroenterology of the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania.

Abstract

Obesity and irritable bowel syndrome (IBS) are prevalent in the United States and cause significant morbidity in those affected. However, it is unclear whether obesity is more prevalent in those affected by IBS or if IBS is more prevalent in obese persons. To evaluate the association between obesity and IBS, a comprehensive review was performed by searching MEDLINE and Embase from 1980 through July 2012. Studies were included if 1 of the outcomes examined the relationship between excess body weight or obesity and IBS. A total of 11 studies (2 pediatric and 9 adult) investigated the relationship between obesity and IBS. The prevalence of obesity in children with IBS ranged from 24.8% to 42%. In adults, the prevalence of IBS in obese subjects varied from 11.6% to 24%, depending on the study population. Two studies did not show increased odds of IBS in obese patients; however, 2 studies showed that symptoms were more severe in obese patients affected by IBS, while 1 of these studies demonstrated that IBS symptom severity improved after bariatric surgery. The findings of this comprehensive review of the literature suggest that the frequency of IBS in obese children and adults is variable and depends on the study population. Due to the heterogeneity in study populations, outcome assessment, and methodology in the existing literature, further studies are needed to determine whether obesity is associated with IBS.

© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.